Litcius/Paper detail

Exosomal microRNAs in cancer-related sarcopenia: Tumor-derived exosomal microRNAs in muscle atrophy

Chenyuan Li, Qi Wu, Zhiyu Li, Zhong Wang, Yi Tu, Chuang Chen, Si Sun, Shengrong Sun, Shengrong Sun, Shengrong Sun

2021Experimental Biology and Medicine13 citationsDOIOpen Access PDF

Abstract

Cancer-associated sarcopenia is a complex metabolic syndrome marked by muscle mass wasting. Muscle wasting is a serious complication that is a primary contributor to cancer-related mortality. The underlying molecular mechanisms of cancer-associated sarcopenia have not been completely described to date. In general, evidence shows that the main pathophysiological alterations in sarcopenia are associated with the degradation of cellular components, an exceptional inflammatory secretome and mitochondrial dysfunction. Importantly, we highlight the prospect that several miRNAs carried by tumor-derived exosomes that have shown the ability to promote inflammatory secretion, activate catabolism, and even participate in the regulation of cellular degradation pathways can be delivered to and exert effects on muscle cells. In this review, we aim to describe the current knowledge about the functions of exosomal miRNAs in the induction of cancer-associated muscle wasting and propose potential treatment strategies.

Topics & Concepts

WastingSarcopeniaMicrovesiclesmicroRNACancerMuscle atrophyAutophagyInflammationAtrophySkeletal muscleBioinformaticsCatabolismDownregulation and upregulationMedicineBiologyCancer researchInternal medicineMetabolismBiochemistryApoptosisGeneMuscle Physiology and DisordersExtracellular vesicles in diseaseExercise and Physiological Responses